Rhythm Pharmaceuticals (RYTM) Tax Provisions (2021 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly Tax Provisions came in at $500000.0 in Q1 2026, up 400.0% year-on-year from $100000.0 in Q1 2025, and up 1712.9% on a QoQ basis from -$31000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Tax Provisions (2021 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 5 years of Tax Provisions data on file, last reported at $500000.0 in Q1 2026.
- On a quarterly basis, Tax Provisions rose 400.0% year-over-year to $500000.0 in Q1 2026; TTM through Mar 2026 was $880000.0, a 335.64% increase from a year earlier, with the FY2025 full-year figure at $497000.0, up 43.64% from the prior year.
- Tax Provisions for Q1 2026 stood at $500000.0, up from -$31000.0 in the prior quarter.
- Over the last five years, Tax Provisions for RYTM reached as high as $500000.0 in Q2 2024 and fell as low as -$344000.0 in Q3 2024.
- Historically, Tax Provisions has averaged $176909.1 across 4 years, with a median of $196000.0 in 2023.
- Across the five-year window, Tax Provisions tumbled 193.48% in 2024 and soared 400.0% in 2026, its largest moves.
- Year by year, Tax Provisions stood at $196000.0 in 2023, then slumped by 127.55% to -$54000.0 in 2024, then surged by 42.59% to -$31000.0 in 2025, then soared by 1712.9% to $500000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $500000.0 in Q1 2026, -$31000.0 in Q4 2025, and $111000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.99 Bn | 6.64 Bn | 52.96 Mn | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Sep 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | -54,000.00 |
| Sep 30, 2024 | -344,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 196,000.00 |
| Sep 30, 2023 | 368,000.00 |
| Sep 30, 2021 | -9.00 Mn |
| Jun 30, 2021 | -5.02 Mn |
| Mar 31, 2021 | 22.01 Mn |